User:TüBioc/sandbox

From Wikipedia, the free encyclopedia
EGF-like domain
Structure of the epidermal growth factor-like domain of heregulin-alpha.[1]
Identifiers
SymbolEGF
PfamPF00008
Pfam clanCL0001
InterProIPR006209
PROSITEPDOC00021
SCOP21apo / SCOPe / SUPFAM
OPM protein1dan
Available protein structures:
Pfam  structures / ECOD  
PDBRCSB PDB; PDBe; PDBj
PDBsumstructure summary
PDB1tpg :86-119 1haf :182-221 1hae :182-221

1hrf :182-221 1hre :182-221 1tozA:456-487 1wv7L:110-141 1j9cL:110-141 1ff7A:110-141 1wqvL:110-141 1bf9 :110-141 1f7mA:110-141 1wssL:110-141 1nl8M:110-141 1w0yL:110-141 1dvaM:110-141 1z6jL:110-141 1fakL:110-141 1f7eA:110-141 1wunL:110-141 1wtgL:110-141 1qfkL:110-141 1o5dL:110-141 1ffmA:110-141 1danL:110-141 1xkbB:90-121 1xkaL:90-121 1apo :90-121 1whf :90-121 1whe :90-121 1ccf :90-121 1edmC:97-128 1ixa :97-128 1pfxL:52-83 1x7aL:52-83 1pz8C:1836-1869 1q56A:1836-1869 1pz7B:1836-1869 1pz9B:1836-1869 1pgfB:37-69 1pthA:37-69 1prhB:37-69 1q4gB:37-69 1pggA:37-69 1ebvA:37-69 1fe2A:37-69 1ht5B:37-69 1cqeB:37-69 1diyA:37-69 2aylA:37-69 1eqgA:37-69 1pgeA:37-69 1igzA:37-69 1ht8A:37-69 1eqhB:37-69 1igxA:37-69 1u67A:37-69 1djjA:37-69 1pxxB:21-54 5coxC:21-54 1ddxA:21-54 1cvuA:21-54 1dd0A:21-54 1cx2B:21-54 3pghC:21-54 4coxB:21-54 1dcxB:21-54 6coxB:21-54 1v0xA:22-54 1g1qA:163-194 1g1sB:163-194 1g1rB:163-194 1fsb :163-194 1esl :143-174 1g1tA:143-174 1nziA:135-171 1k36A:68-103 1k37A:68-103 1ivoD:976-1012 1jl9B:976-1012 1nqlB:976-1012 1a3p :982-1018 1epj :982-1018 1epg :982-1018 3egf :982-1018 1egf :982-1018 1eph :982-1018 1epi :982-1018 1ioxA:69-104 1ip0A:69-104 4tgf :47-82 2tgf :47-82 1moxD:47-82 1yug :47-82 1yuf :47-82 3tgf :47-82 1xdtR:108-143 1ijqA:667-711 1n7dA:667-711 1xfeA:318-352 1i0uA:318-352 1hj7A:318-352 1hz8A:318-352 1rfnB:134-170 1ezqB:129-164 1c5mF:129-164 1ksnB:129-164 1ioeL:129-164 2bokL:129-164 1hcgB:129-164 1iqjL:129-164 1iqlL:129-164 1nfuB:129-164 1faxL:129-164 1lpzA:129-164 1f0rB:129-164 1g2lB:129-164 1g2mB:129-164 1nfwB:129-164 1p0sL:129-164 1nfxB:129-164 1v3xB:129-164 1iqkL:129-164 1lqdA:129-164 1lpkA:129-164 1nfyB:129-164 1iqgL:129-164 1wu1B:129-164 1fjsL:129-164 1lpgA:129-164 1iqhL:129-164 1iqiL:129-164 1f0sB:129-164 1mq5L:129-164 1iqmL:129-164 1iqeL:129-164 1iqfL:129-164 1iqnL:129-164 1mq6L:129-164 1kyeB:129-164 1kigL:129-164 1yo8A:652-691 1gl4A:388-423 1h4uA:395-423

1cejA:1574-1617 1ob1F:474-517
EGF-like domain
crystal structure of the extracellular segment of integrin alphavbeta3
Identifiers
SymbolEGF_2
PfamPF07974
Pfam clanCL0001
InterProIPR013111
Available protein structures:
Pfam  structures / ECOD  
PDBRCSB PDB; PDBe; PDBj
PDBsumstructure summary

EGF-like domain The EGF (epidermal growth factor)-like domain is an evolutionary conserved protein domain. It derives its name from the epidermal growth factor in which it was first described. It comprises about 30 to 40 amino-acid residues and has been found in a large number of mostly animal proteins [2] [3]. All these domains are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted. An exception to this is the prostaglandin H/G synthase. The EGF-like domain includes 6 cysteine residues which in the epidermal growth factor have been shown to be involved in 3 disulfide bonds. The structures of two 4-disulfide EGF-domains have been solved: laminin and integrin. The main structure of EGF-like domains is a two-stranded β-sheet followed by a loop to a short C-terminal, two-stranded β-sheet. These two β-sheets are usually denoted as the major (N-terminal) and minor (C-terminal) sheets [4].

EGF-like domain subtypes

Despite the similarities of EGF-like domains, distinct domain subtypes have been identified [5]. The two main types of EGF-like domains suggested are the human EGF-like (hEGF) domain and the complement C1r-like (cEGF) domain [4], which was first identified in the human complement protease C1r [5]. C1r is a highly specific serine protease initiating the classical pathway of complement activation during immune response [6]. Both the hEGF- and cEGF-like domains contain three disulfides and derive from a common ancestor that carried four disulfides of which two cysteines were lost during evolution. . Furthermore, cEGF-like domains can be divided in two subtypes (1 and 2) whereas all hEGF-like domains belong to one subtype [4]. The differentiation of cEGF-like and hEGF-like domains and their subtypes is based on structural features and the connectivity of their disulfide bonds. cEGF- and hEGF-like domains have a distinct shape and orientation of the minor sheet and one C-terminal half-cystine has a different position. The lost cysteines of the common ancestor differ between cEGF- and hEGF-like domains and hence these types contain distinct disulfide bonds. The differentiation of cEGF into subtype 1 and 2, which probably occurred after its split from hEGF, is based on different residue numbers between the distinct half-cystines. An N-terminal located calcium binding motif can be found in hEGF- as well as in cEGF-like domains and is therefore not suitable to tell them apart [4]. hEGF- and cEGF-like domains also contain post-translational modifications, which are often unusual and differ between hEGF- and cEGF-like domains. These post-translational modifications include O-glycosylations, mostly O-fucose modifications, and β-hydroxylation of aspartate and asparagine residues. O-fucose modifications have only been detected in hEGF-like domains and they are important for the proper folding of the hEGF-like domain. β-Hydroxylation appears in hEGF- and cEGF-like domains, the former is hydroxylated on an aspartic acid while the latter is hydroxylated on an asparagine residue. The biological role of this post-translational modification is unclear [4], but mice with a knockout of the aspartyl-β-hydroxylation enzyme show developmental defects [7]. Proteins containing an EGF-like domain are widespread and can either carry solely a hEGF-like ore cEGF-like domain or in contrast both types mixed together. In many mitogenic and developmental proteins such as Notch and Delta the EGF-like domains are only of the hEGF type. Other proteins contain only cEGF such as thrombomodulin and the LDL-receptor. In mixed EGF-proteins the hEGF- and cEGF-like domains are grouped together with the hEGFs always being N-terminal of the cEGFs. Such proteins are involved in blood coagulation or are components of the extracellular matrix like fibrillin and LTBP-1 (Latent-transforming growth factor beta-binding protein 1). Additionally to the mentioned three disulfide hEGF- and cEGF-like types, there are proteins carrying a four-disulfide EGF-like domain like laminin and integrin [4]. The two main EGF-like domain subtypes hEGF and cEGF are not just distinct in their structure and conformation but additionally have different functions. This hypothesis is substantiated by research on LTBP-1. LTBP-1 anchors the transforming growth factor β (TGF-β) to the extracellular matrix. hEGF-like domains play a role in targeting the LTBP-1/TGF-β assembly to the extracellular matrix. Once attached to the extracellular matrix, TGF-β dissociates from hEGF subunits to afford its subsequent activation. cEGF-like domains seem to play an unspecific role in this activation by promoting the cleavage of LTBP-1 from TGF-β by various proteases [4]. In conclusion, although distinct EGF-like domains are grouped, subtypes can be clearly separated by their sequence, conformation and, most importantly, their function.

The EGF-like domain in the immune system and apoptosis

Selectins, a group of proteins that are involved in leukocyte rolling towards a source of inflammation, contain an EGF-like domain along with a lectin domain and short consensus repeats (SCRs) [8] [9]. The functions of the EGF-like domain vary amongst the different selectin types. Kansas and co-workers were able to show that the EGF-like domain is not required for maximal cellular adhesion in L-selectin (expressed on lymphocytes). However, it is involved in both ligand recognition and adhesion in P-selectin (expressed on platelets) and may also be involved in protein-protein interactions. It has been suggested that the interactions between lectin domains and carbohydrate ligands might be calcium-dependent [8]. Interestingly, immature human dendritic cells appear to require interactions with the EGF-like domains of selectins during their maturation process. Blocking of this interaction induced with monoclonal anti-EGF-like domain antibodies prevents dendritic cell maturation. The immature cells fail to activate T-cells and produce less interleukin 12 than wild-type dendritic cells [10]. Phan et al. could show that the artificial insertion of an N-glycosylation site into the EGF-like domains in P- and L-selectins increased the affinities of selectins to their ligands and therefore led to slower rolling [9]. Therefore, the EGF-like domains seem to play a crucial role in leukocyte movements towards inflammatory stimuli. The EGF-like domain is also part of laminins, an important group of extracellular proteins. The EGF-like domains are usually masked in intact membranes, but become exposed when the membrane is destroyed, e.g. during inflammation processes, thereby stimulating membrane growth and restoring damaged membrane parts [11]. Moreover, the EGF-like domain repeats of the stabilin-2 domain have been shown to specifically recognize and bind apoptotic cells, probably by recognizing phosphatidylserine, an apoptotic cell marker (“eat me-signal”) [12]. Park et al. further demonstrated that the domains are able to competitively impair recognition of apoptotic cells by macrophages. Concluding, the EGF-like domain appears to play a vital role in immune responses as well as in eliminating dead cells from the organism.


Calcium-binding EGF-like domains


Calcium-binding EGF-like domains (cbEGF-like domains) play a seminal role in diseases such as the Marfan syndrome [13] or the X-chromosome linked hemorrhagic disorder hemophilia B [14] and are among the most abundant extracellular calcium-binding domains [15]. Importantly, cbEGF- like domains impart specific functions to a variety of proteins in the blood clotting cascade. Examples include the coagulation factors VII, IX and X, protein C and its cofactor protein S [15]. Calcium-binding EGF-like domains are typically composed of 45 amino acids, arranged as two antiparallel beta sheets [15]. Several cysteine residues within this sequence form disulfide bridges.


Interestingly, cbEGF-like domains show no significant structural deviations from EGF-like domains, however, as the name suggests, cbEGF-like domains bind a single calcium ion. The binding affinity to calcium varies widely and often depends on adjacent domains [15]. The consensus motif for calcium binding is Asp-Leu/Ile-Asp-Gln-Cys. Coordination of calcium strongly correlates with an unusual posttranslational modification of cbEGF-like domains: Either an asparagine or aspartate is beta-hydroxylated, giving rise to erythro-beta-hydroxyasparagine (Hyn) or erythro-beta-hydroxyaspartic acid (Hya), respectively. Hya can be found in the N-terminal cbEGF module (see below) of factors IX, X, and protein C. The Hyn modification appears to be more prevalent than Hya and has been shown to occur in fibrillin-1, an extracellular matrix protein [16]. Both modifications are catalyzed by the dioxygenase Asp/Asn-beta-hydroxylase [17], and, in eukaryotes, are unique to EGF domains [15]. Further posttranslational modifications have been reported. Glycosylation in the form of O-linked di- or trisaccharides may occur at a serine residue between the first two cysteines of blood coagulation factors VII and IX [18] [19] [20]. Factor VII exhibits an O-linked fucose at Ser60 [20].


Importantly, multiple cbEGF domains are often connected by one or two amino acids to form larger, repetitive arrays, here referred to as 'cbEGF modules'. In the blood clotting cascade, coagulation factors VII, IX and X, and protein C contain a tandem of two cbEGF modules, whereas protein S has four. Impressivley, in fibrillin-1 and fibrillin-2, 43 cbEGF modules have been found [21]. The modularity of these proteins adds complexity to protein-protein- but also module-module-interaction. In factors VII, IX and X, the two cbEGF modules are preceded by an N-terminal gamma-carboxyglutamic acid (Gla) containing module (the Gla module) [15]. In vitro studies on the Gla-cbEGF tandem isolated from factor X revealed a Kd-value of 0.1 mM for calcium binding [18]. The free calcium blood plasma concentrations is approximately 1.2 mM. Surprisingly, in the absence of the Gla module, the cbEGF module exhibits a Kd-value of 2.2 mM for calcium [17]. Thus, the presence of the Gla module increases calcium affinity 20-fold. Similarly, the activity of Gla and Ser proteinase modules are modified by the cbEGF modules. In the absence of calcium, the Gla and cbEGF modules are highly mobile. As the cbEGF module associates with calcium, however, movement of the Gla module is significantly restricted because the cbEGF module now adopts a conformation that ’locks’ the neighboring Gla module in a fixed position [22] [23]. Therefore, calcium coordination induces conformational changes which, in turn, might modulate enzymatic activity.


Impaired coordination of calcium can result in serious disorders. Defective calcium binding to coagulation factor IX contributes to the development of hemophilia B. Individuals afflicted with this hereditary disease tend to develope hemorrhages, potentially leading to life-threatening conditions. The cause of hemophilia B is a decreased activity or deficiency of blood coagulation factor IX. Point mutations resulting in decreased affinity of factor IX to calcium are thought to be implicated in this bleeding disorder [15]. On a molecular basis, it appears that hemophilia B can be the result of an impaired ability to localize the Gla module efficiently, as usually occurs after calcium coordination by the cbEGF module in fully functional factor IX [15]. This defect is thought to impair the biological function of factor IX. A similar problem occurs in patients suffering from hemophilia B and carrying a mutation (Glu78Lys) in factor IX that prevents interaction of the two cbEGF modules with one another [15]. Conversely, in healthy individuals, Glu78 in the first cbEGF-module contacts Arg94 in the second cbEGF module and thereby aligns both modules [24].

Thus, domain-domain interactions (partially facilitated by calcium coordination) are crucial for the catalytic activity of proteins involved in the blood-clotting cascade.

Proteins containing this domain[edit]

Below is a list of human proteins containing the EGF-like domain:

See also[edit]

References[edit]

  1. ^ Nagata K, Kohda D, Hatanaka H; et al. (August 1994). "Solution structure of the epidermal growth factor-like domain of heregulin-alpha, a ligand for p180erbB-4". EMBO J. 13 (15): 3517–23. doi:10.1002/j.1460-2075.1994.tb06658.x. PMC 395255. PMID 8062828. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  2. ^ Downing AK, Knott V, Werner JM, Cardy CM, Campbell ID, Handford PA (May 1996). "Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders". Cell. 85 (4): 597–605. doi:10.1016/S0092-8674(00)81259-3. PMID 8653794.{{cite journal}}: CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  3. ^ Bork P, Downing AK, Kieffer B, Campbell ID (May 1996). "Structure and distribution of modules in extracellular proteins". Q. Rev. Biophys. 29 (2): 119–67. doi:10.1017/S0033583500005783. PMID 8870072.{{cite journal}}: CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  4. ^ a b c d e f g Wouters MA, Rigoutsos I, Chu CK, Feng LL, Sparrow DB, Dunwoodie SL (2005). "Evolution of distinct EGF domains with specific functions". Protein Science. 14 (4): 1091–103. doi:10.1110/ps.041207005. PMC 2253431. PMID 15772310.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  5. ^ a b Bersch B, Hernandez J-F, Marion D, Arlaud GJ (1998). "Solution Structure of the Epidermal Growth Factor (EGF)-like Module of Human Complement Protease C1r, an Atypical Member of the EGF Family". Biochemistry. 37 (5): 1204–14. doi:10.1021/bi971851v. PMID 9477945.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  6. ^ Circolo A, Garnier G, Volanakis JE (2003). "A novel murine complement-related gene encoding a C1r-like serum protein". Molecular Immunology. 39 (14): 899–906. doi:10.1016/S0161-5890(02)00283-3. PMID 12686506.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  7. ^ Stenflo J, Ohlin AK, Owen WG, Schneider WJ (1988). "beta-Hydroxyaspartic acid or beta-hydroxyasparagine in bovine low density lipoprotein receptor and in bovine thrombomodulin". Journal of Biological Chemistry. 263 (1): 21–24. doi:10.1016/S0021-9258(19)57350-1. PMID 2826439.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  8. ^ a b Kansas GS, Saunders KB, Ley K; et al. (1994). "A role for the epidermal growth factor-like domain of P-selectin in ligand recognition and cell adhesion". J Cell Biol. 124 (4): 609–18. doi:10.1083/jcb.124.4.609. PMC 2119911. PMID 7508943. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  9. ^ a b Phan UT, Waldron TT, Springer TA (2006). "Remodeling of the lectin-EGF-like domain interface in P- and L-selectin increases adhesiveness and shear resistance under hydrodynamic force". Nat Immunol. 7 (8): 883–9. doi:10.1038/ni1366. PMC 1764822. PMID 16845394.{{cite journal}}: CS1 maint: multiple names: authors list (link) Cite error: The named reference "pmid 16845394" was defined multiple times with different content (see the help page).
  10. ^ Zhou T, Zhang Y, Sun G; et al. (2006). "Anti-P-selectin lectin-EGF domain monoclonal antibody inhibits the maturation of human immature dendritic cells". Exp Mol Pathol. 80 (2): 171–6. doi:10.1016/j.yexmp.2005.10.004. PMID 16413535. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  11. ^ Löffler, G; Petrides, PE; Heinrich, PC (1997). Biochemie und Pathobiochemie (5th ed.). Berlin, Heidelberg: Springer-Verlag. p. 747. ISBN 3-540-59006-4.
  12. ^ Park SY, Kim SY, Jung MY; et al. (2008). "Epidermal growth factor-like domain repeat of tabilin-2 recognizes phosphatidylserine during cell corpse clearance". Mol Cell Biol. 28 (17): 5288–98. doi:10.1128/MCB.01993-07. PMC 2519725. PMID 18573870. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  13. ^ Handford PA, Downing AK, Rao Z, Hewett DR, Sykes BC, Kielty CM (1991). "The calcium binding properties and molecular organization of epidermal growth factor-like domains in human fibrillin-1". J. Biol. Chem. 270 (12): 6751–6. doi:10.1074/jbc.270.12.6751. PMID 7896820.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  14. ^ Handford PA, Mayhew M, Baron M, Winship PR, Campbell ID, Brownlee GG (1991). "Key residues involved in calcium-binding motifs in EGF-like domains". Nature. 351 (6322): 164–7. doi:10.1038/351164a0. PMID 2030732.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  15. ^ a b c d e f g h i Stenflo J, Stenberg Y, Muranyi A; Stenberg; Muranyi (2000). "Calcium-binding EGF-like modules in coagulation proteinases: function of the calcium ion in module interactions". Biochimica et Biophysica Acta. 1477 (1–2): 51–63. doi:10.1016/s0167-4838(99)00262-9. PMID 10708848.{{cite journal}}: CS1 maint: date and year (link) CS1 maint: multiple names: authors list (link)
  16. ^ Glanville RW, Qian RQ, McClure DW, Maslen CL; et al. (1994). "Calcium binding, hydroxylation, and glycosylation of the precursor epidermal growth factor-like domains of fibrillin-1, the Marfan gene protein". J. Biol. Chem. 269 (43): 26630–4. doi:10.1016/S0021-9258(18)47065-2. PMID 7929395. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  17. ^ a b Jia S, VanDusen WJ, Diehl RE; et al. (1992). "cDNA Cloning and Expression of Bovine Aspartyl (Asparaginyl) Beta-Hydroxylase". J. Biol. Chem. 267 (20): 14322–7. doi:10.1016/S0021-9258(19)49715-9. PMID 1378441. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  18. ^ a b Valcarce C, Selander-Sunnerhagen M, Tämlitz AM, Drakenberg T, Björk I, Stenflo J (1996). "Calcium Affinity of the NH2-terminal Epidermal Growth Factor-like Module of Factor X". J. Biol. Chem. 268 (35): 26673–8. doi:10.1016/S0021-9258(19)74365-8. PMID 8253800.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  19. ^ Nishimura H, Kawabata S, Kisiel W; et al. (1989). "Identification of a disaccharide (Xyl-Glc) and a trisaccharide (Xyl2-Glc) O-glycosidically linked to a serine residue in the first epidermal growth factor-like domain of human factors VII and IX and protein Z and bovine protein Z". J. Biol. Chem. 264 (34): 20320–5. doi:10.1016/S0021-9258(19)47065-8. PMID 2511201. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  20. ^ a b Bjoern S, Foster D, Thim L; et al. (1991). "Human Plasma and Recombinant Factor VII". Biol. Chem. 266 (17): 11051–7. doi:10.1016/S0021-9258(18)99126-X. PMID 1904059. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  21. ^ Piha-Gossack A, Sossin W, Reinhardt DT; et al. (2012). "The evolution of extracellular fibrillins and their functional domains". PLOS ONE. 7 (3): 33560. doi:10.1371/journal.pone.0033560. PMC 3306419. PMID 22438950. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  22. ^ Sunnerhagen M, Forsen S, Hoffren A, Drakenberg T, Teleman O, Stenflo J (1995). "Structure of the Ca(2+)-free Gla domain sheds light on membrane binding of blood coagulation proteins". Nat. Struct. Biol. 2 (6): 504–9. doi:10.1038/nsb0695-504. PMID 7664114.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  23. ^ Sunnerhagen M, Olah GA, Stenflo J, Forsen S, Drakenberg T, Trewhella J (1996). "The relative orientation of Gla and EGF domains in coagulation factor X is altered by Ca2+ binding to the first EGF domain. A combined NMR-small angle X-ray scattering study". Biochem. 35 (36): 11547–59. doi:10.1021/bi960633j. PMID 8794734.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  24. ^ Christophe OD, Lenting PJ, Kolkman JA, Brownlee GG, Mertens K (1988). "Blood coagulation factor IX residues Glu78 and Arg94 provide a link between both epidermal growth factor-like domains that is crucial in the interaction with [[Factor_viii|factor VIII]] light chain". J. Biol. Chem. 273 (1): 222–7. doi:10.1074/jbc.273.1.222. PMID 9417068. {{cite journal}}: URL–wikilink conflict (help)CS1 maint: multiple names: authors list (link)


Category:Protein domains Category:Single-pass transmembrane proteins

Retrieved from "https://en.wikipedia.org/w/index.php?title=User:TüBioc/sandbox&oldid=1168322189"